MMS Holdings

Detroit, United States Founded: 2006 • Age: 20 yrs
Data-focused clinical research and regulatory services are provided.

About MMS Holdings

MMS Holdings is a company based in Detroit (United States) founded in 2006. Data-focused clinical research and regulatory services are provided. The company has 247 employees. MMS Holdings has completed 1 acquisition, including Exploristics. Its website mmsholdings.com draws about 13 thousand monthly visits. Its Indian entity Mmsh Clinical Research Private Limited reported revenue of β‚Ή60.85 Cr. MMS Holdings offers products and services including Regulatory Submissions and Biometrics Support.

Company details

MMS Holdings was founded in 2006 and is headquartered in Detroit, United States. Clinical research and regulatory services in the pharmaceutical sector are offered, with a focus on data management. Drug development is supported through services including biometrics, regulatory submissions, safety management, therapeutic expertise, and functional outsourcing. AI and technology are utilized to improve operational efficiency. Additional capabilities encompass medical writing, biostatistics, data science, and drug safety monitoring.

Key Metrics
  • Indian entity revenue
    ₹60.85 Cr

    FY 2025 · +4% YoY

  • Indian entity net profit
    ₹7.13 Cr

    FY 2025 · 12% margin

  • Indian entity EBITDA
    ₹9.86 Cr

    FY 2025 · 16% margin

  • Investors
  • Employee Count
    247
  • Investments & Acquisitions

Products & Services of MMS Holdings

MMS Holdings offers a comprehensive portfolio of products and services, including Regulatory Submissions and Biometrics Support.

Regulatory Submissions
Regulatory Services

Regulatory submissions are handled by MMS from IND applications through to marketing authorizations, ensuring compliance with global standards.

Biometrics Support
Data Services

Biometrics support is provided by MMS, including data management and statistical consulting to optimize clinical trial outcomes.

Apps and channels of MMS Holdings

its YouTube channel MMS Holdings has 250 subscribers and 24 videos.

MMS Holdings
YouTube 250 subscribers 24 videos Science & Technology
Open channel

Videos from MMS Holdings

The most watched videos on MMS Holdings's YouTube channel, MMS Holdings (250 subscribers). Click a video to play it here.

New EU Clinical Trials Regulation: What’s New?
3.9K views
Preparing for an FDA inspection – what you need to know
2.2K views
Authoring Efficiencies and Cross-functional Strategies: Clinical Study Report and Beyond
1.2K views
Modernizing the Functional Service Provider (FSP) Relationship: Innovations to Bring Value
982 views

More on MMS Holdings.

Funding Insights of MMS Holdings

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of MMS Holdings with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2022Private Equity Round––
Valuation history

1 investors in total: 1 institutional.

Investors in MMS Holdings

MMS Holdings has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lindsay Goldberg.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
PE firm invests in the US
lindsaygoldbergllc.comNew York, United States
Premium access

Investor details for MMS Holdings

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Mmsh Clinical Research Private Limited (MMS Holdings)

Mmsh Clinical Research Private Limited is the primary company behind MMS Holdings. The board of Mmsh Clinical Research Private Limited currently have 2 directors; the longest-serving is Uma Sharma, appointed in 2007. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Uma Sharma
DIN 01449696
Director13 Sep 200719 yrs 2 moMmsh Clinical Research Private Limited
Sethuraman Venkatesan
DIN 10095727
Director31 Mar 20233 yrs 7 moMmsh Clinical Research Private Limited

People of MMS Holdings

71 people are tracked at MMS Holdings (30 in leadership, 41 in team); the tracked headcount is 247.

NameRoleGroup
Michelle Gayari
Executive Vice PresidentLeadership
Venkata Atkuri
Director, Quality And ComplianceLeadership
Kyle Arenofsky
Director Of Business DevelopmentLeadership
Mark Bernath
Director, Business DevelopmentLeadership
Louise van Aswegen
DirectorLeadership
CEOLeadership
Mohamad Zahreddine
Chief Information OfficerLeadership
Prasad M. Koppolu
COOLeadership
Sam Venkat
CFOLeadership
Ben Dudley
Chief Commercial Officer (cco)Leadership
Tyler Deloach
Director Of Fp&aLeadership
Evan Picard
Chief Financial OfficerLeadership
James Zee
Director, Global Head Of ProgrammingLeadership
Christopher Schoonmaker
Chief Operating OfficerLeadership
Cory Pensa
Director, Business DevelopmentLeadership
Duane Robinson
Director, Business Development And OperationsLeadership
Beth Fehrle
Director, OperationsLeadership
Chris Hurley
Director, Data ScienceLeadership
Seetharaman Sankaran
Associate Director, It, Quality And ComplianceLeadership
Jim Balcom
Director, Partnerships And IT GovernanceLeadership

51 more people are available in the full profile.

Premium access

Complete people profiles for MMS Holdings

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of MMS Holdings

Figures of Mmsh Clinical Research Private Limited, the primary company behind MMS Holdings, for FY 2025. Revenue was ₹60.85 Cr (+4% year on year). Net profit was ₹7.13 Cr (12% margin). EBITDA was ₹9.86 Cr (16% margin). Revenue has grown at a compounded annual rate of +21% over three years and +22% over five years.

  • ₹60.85 CrRevenue · FY 2025 · +4% YoY
  • ₹7.13 CrNet profit · 12% margin
  • ₹9.86 CrEBITDA · 16% margin
  • ₹1 LakhPaid-up capital
  • 205Employees (provident fund records)
  • +21%Revenue CAGR, 3 years
  • +22%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Mmsh Clinical Research Private Limited are on its company page.

Premium access

Detailed financial statements for MMS Holdings

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MMS Holdings

MMS Holdings has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Exploristics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Data analysis and management services are provided to clients.
exploristics.comBelfast, United Kingdom2009Feb 2025β€’β€’β€’β€’
Premium access

Complete acquisition details for MMS Holdings

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of MMS Holdings

3 dated milestones of MMS Holdings across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded MMS Holdings is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Exploristics.

Web traffic of MMS Holdings

The website of MMS Holdings (mmsholdings.com) receives about 12.9K visits a month and ranks #1,472,608 among all websites worldwide, #1,930 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    12.9K

    ▼ 29.3% vs previous month

  • Unique visitors
    7.9K

    per month

  • Global rank
    #1,472,608

    among all websites

  • Category rank
    #1,930

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with MMS Holdings. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
acadia.com
100%
37.8K#803,210View details
hrbopenresearch.org
90%
#1,645,254View details
unipharmus.com
unipharmus.com
85%
–
exac.com
75%
13.2K#1,893,670View details
indegene.com
70%
143.6K#217,128View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for MMS Holdings

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MMS Holdings

MMS Holdings was founded in 2006 and raised its 1st funding round 16 years after it was founded.

MMS Holdings is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.

MMS Holdings has 247 employees.

The primary company behind MMS Holdings, Mmsh Clinical Research Private Limited, reported revenue of β‚Ή60.85 Cr for FY 2025, up 4% year on year.

MMS Holdings was founded in 2006 and is headquartered in Detroit, United States. Clinical research and regulatory services in the pharmaceutical sector are offered, with a focus on data management. Drug development is supported through services including biometrics, regulatory submissions, safety management, therapeutic expertise, and functional outsourcing. AI and technology are utilized to improve operational efficiency. Additional capabilities encompass medical writing, biostatistics, data science, and drug safety monitoring.

MMS Holdings offers Regulatory Submissions and Biometrics Support.

MMS Holdings has made 1 acquisition, including Exploristics.

MMS Holdings has 1 investor. Key investors include Lindsay Goldberg.

MMS Holdings operates through Mmsh Clinical Research Private Limited.

The legal entities of MMS Holdings currently have 2 directors, including Sethuraman Venkatesan, Uma Sharma.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available